Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $215M
Founded date: 2016
Investors 5
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | S32 | s32.com |
| - | TCG Crosso... | tcgcrossov... |
| - | Illumina V... | illuminaVe... |
| - | Ono Ventur... | onoventure... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.11.2021 | Series B | $215M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 12.03.2024 | Allogene Therapeutics and Arbor Biotechnologies Announce Glo... | - | globenewsw... |
| 10.11.2021 | Arbor Biotechnologies raises $215M to treat genetic diseases | Arbor Biotechnologies has raised a $215 million Series B co-led by Ally Bridge Group, TCG Crossover ... | pitchbook.... |
| 09.11.2021 | Arbor Biotechnologies, Inc. announced that it has received $... | On November 9, 2021, Arbor Biotechnologies, Inc. closed the transaction. The company has received $2... | marketscre... |
| 09.11.2021 | Arbor Biotechnologies Closes $215 Million Oversubscribed Ser... | The most extensive toolbox of proprietary genomic editors in the industry to enable development of c... | marketscre... |
| 09.11.2021 | Arbor Biotechnologies Closes $215 Million Oversubscribed Ser... | - | tcgcrossov... |
| 09.11.2021 | Arbor Biotechnologies Closes $215 Million Oversubscribed Ser... | The most extensive toolbox of proprietary genomic editors in the industry to enable development of c... | ally-bridg... |
| 09.11.2021 | Arbor Biotechnologies Closes $215 Million Oversubscribed Ser... | The most extensive toolbox of proprietary genomic editors in the industry to enable development of c... | globenewsw... |
| 24.08.2021 | Vertex Pharmaceuticals : and Arbor Biotechnologies Establish... | Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell ... | marketscre... |
| - | Ono Venture Investment Invests in Arbor Biotechnologies. (A... | - | onoventure... |